Avenna at SEHTA Conference



In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.